UnknownPhase 3NCT00207792

Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation

Studying Graft versus host disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre National de Greffe de Moelle Osseuse
Principal Investigator
Tarek Ben Othman, MD
Centre National de Greffe de Moelle Osseuse
Intervention
filgrastim(drug)
Enrollment
160 enrolled
Eligibility
16-45 years · All sexes
Timeline
2005

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00207792 on ClinicalTrials.gov

Other trials for Graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Graft versus host disease →

← Back to all trials